ICON Central Laboratories Launches New Remote Data Access ToolFARMINGDALE, NY , 15th January 2007, ICON Central Laboratories, a division of ICON plc (NASDAQ:ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the release of ICOlabs, an innovative, remote data access tool for it’s pharmaceutical and biotechnology clients.
The ICOLabs product is a secure, completely web-based application that incorporates a new digital dashboard feature that enables users to readily access study indicators as well as custom reports. In addition, the system offers newly designed test result trending with numeric or graphic displays for an individual study subject or user-designated group of subjects. It also provides “point and click” access to laboratory reports and investigator information, site-specific kit inventory information and detailed reports pertaining to long term specimen storage and shipments.
“The new product is the culmination of over a year of collaboration with our users to develop an innovative, comprehensive tool to retrieve and manage laboratory result data,” commented John Reinert, Vice President of Information Technology for ICON Central Laboratories. “Our goal was to raise the standard for such products in the industry by providing better access to information along with more intuitive navigation. We also wanted to develop a system that truly worked for all of our users, whether they are Project Managers, Clinical and Safety Monitors or CRAs,” Reinert added.
ICON Central Laboratories will begin making the new system available to its clients in January.
About ICON Central Laboratories
ICON Central Laboratories, a division ICON plc, is headquartered in Farmingdale New York and provides global central laboratory services, dedicated exclusively to clinical trials, through its core facilities in New York, Dublin & Singapore. Its comprehensive service portfolio ranges from safety testing and biomarkers to custom flow cytometry. Since becoming part of ICON plc in 2000, ICON Central Laboratories has managed over 1000 clinical studies supporting investigators in 60 countries. ICON Central Laboratories is CAP accredited and works according to globally consistent processes that conform to the ISO 17025 quality certification. Further information is available at www.icolabs.com
About ICON plc
ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The company specializes in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies. ICON teams have successfully conducted over 1900 development projects and over 2300 consultancy engagements across all major therapeutic areas. ICON currently has over 4100 employees, operating from 48 locations in 30 countries. Further information is available at www.iconclinical.com
Back to press releases
The ICOLabs product is a secure, completely web-based application that incorporates a new digital dashboard feature that enables users to readily access study indicators as well as custom reports. In addition, the system offers newly designed test result trending with numeric or graphic displays for an individual study subject or user-designated group of subjects. It also provides “point and click” access to laboratory reports and investigator information, site-specific kit inventory information and detailed reports pertaining to long term specimen storage and shipments.
“The new product is the culmination of over a year of collaboration with our users to develop an innovative, comprehensive tool to retrieve and manage laboratory result data,” commented John Reinert, Vice President of Information Technology for ICON Central Laboratories. “Our goal was to raise the standard for such products in the industry by providing better access to information along with more intuitive navigation. We also wanted to develop a system that truly worked for all of our users, whether they are Project Managers, Clinical and Safety Monitors or CRAs,” Reinert added.
ICON Central Laboratories will begin making the new system available to its clients in January.
About ICON Central Laboratories
ICON Central Laboratories, a division ICON plc, is headquartered in Farmingdale New York and provides global central laboratory services, dedicated exclusively to clinical trials, through its core facilities in New York, Dublin & Singapore. Its comprehensive service portfolio ranges from safety testing and biomarkers to custom flow cytometry. Since becoming part of ICON plc in 2000, ICON Central Laboratories has managed over 1000 clinical studies supporting investigators in 60 countries. ICON Central Laboratories is CAP accredited and works according to globally consistent processes that conform to the ISO 17025 quality certification. Further information is available at www.icolabs.com
About ICON plc
ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The company specializes in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies. ICON teams have successfully conducted over 1900 development projects and over 2300 consultancy engagements across all major therapeutic areas. ICON currently has over 4100 employees, operating from 48 locations in 30 countries. Further information is available at www.iconclinical.com